# Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB

> **NCT04856644** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 333 (actual)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

- **DRUG:** 4-month rifapentine-based regimen

## Key facts

- **NCT ID:** NCT04856644
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2024-07-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04856644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04856644, "Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04856644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*